Vigil Neuroscience

News

Sanofi bids to add a drug candidate for Alzheimer's disease to its neurology pipeline via the acquisition of US biotech Vigil Neuroscience.

News

The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.